🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: The disease follicular lymphoma (FL) develops when the body ma...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-22
Trial ID
NCT03789240
This open-label, international, multicenter study will investigate the safe...
Status
Completed
Location
Southern Cancer Center, PC
Start Date
2014-12-01
Trial ID
NCT02187861
Treatments Being Tested
A randomized trial of long-term dosage of rituximab in multiple sclerosis...
Status
Unknown
Location
Anders Svenningsson
Start Date
2018-07-04
Trial ID
NCT03979456
Treatments Being Tested
The purpose of this study is to evaluate biosimilarity between test product...
Status
Completed
Location
Clinical Centre Banja Luka Location Paprikovac
Start Date
2013-05
Trial ID
NCT02468791
Treatments Being Tested
The study hypothesis is that a "reinforced" pneumococcal combined vaccine s...
Status
Completed
Location
Pôle de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques " Hôpital Cochin, Assistance Publique-Hôpitaux de Paris
Start Date
2018-02-05
Trial ID
NCT03069703
Thrombotic thrombocytopenic purpura (TTP) is a rare disorder that causes bl...
Status
Terminated
Location
University of Alabama, Birmingham
Start Date
2009-04
Trial ID
NCT00799773
Treatments Being Tested
Pemphigus is a severe autoimmune blistering disease mediated by circulating...
Status
Completed
Location
Department of Dermatology, University of Luebeck
Start Date
2008-01
Trial ID
NCT00656656
Treatments Being Tested
Rituximab, an anti CD-20 monoclonal antibody targeting B lymphocytes is pre...
Status
Completed
Location
Rhumatologie, CHRU de BREST
Start Date
2015-03-09
Trial ID
NCT02304354
Treatments Being Tested
The purpose of this study is to determine whether rituximab as an adjuvant ...
Status
Terminated
Location
General Hospital Vienna, Dep. of Dermatology, Division of Immunology and Infectious Diseases
Start Date
2007-10
Trial ID
NCT01032122
Treatments Being Tested
This is an open-label Phase I/II trial to assess the feasibility and safety...
Status
Completed
Location
University of Pittsburgh Medical Center
Start Date
2011-03
Trial ID
NCT01266317
Treatments Being Tested